Form 13-F position report

RENEO PHARMACEUTICALS INC

Reported by Jefferies Group LLC

RPHM CUSIP 75974E103 Manager CIK 0001084580

Reported 0 shares, down 21,328 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 62704
2022-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for RENEO PHARMACEUTICALS INC held by Jefferies Group LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2022 Reduced 0 -21,328 (-100.0%) 0 $0 2022-08-15
Q1 2022 New 21,328 +21,328 (0.0%) < 0.01% $62,704 2022-05-16

Who else reported the position

47 managers reported RENEO PHARMACEUTICALS INC for Q2 2022.

Managers reporting RENEO PHARMACEUTICALS INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Unchanged 4,786,921 0 0.65% $12,685,000 5 qtrs
Novo Holdings A S Unchanged 3,430,377 0 0.45% $9,090,000 5 qtrs
RiverVest Venture Management LLC Unchanged 2,409,220 0 9.38% $6,384,000 5 qtrs
Abingworth LLP Unchanged 2,073,957 0 1.73% $5,413,000 5 qtrs
Rock Springs Capital Management LP Unchanged 1,143,185 0 0.09% $3,029,000 5 qtrs
Aisling Capital Management LP Unchanged 886,075 0 1.68% $2,348,000 5 qtrs
FRANKLIN RESOURCES INC Reduced 407,605 -901 < 0.01% $1,080,000 5 qtrs
VANGUARD GROUP INC Reduced 318,814 -42,067 < 0.01% $845,000 5 qtrs
Ikarian Capital LLC Unchanged 185,597 0 0.09% $491,000 4 qtrs
CITADEL ADVISORS LLC New 172,585 +172,585 < 0.01% $457,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.